DERMABAC Trademark

Trademark Overview


On Monday, September 30, 2002, a trademark application was filed for DERMABAC with the United States Patent and Trademark Office. The USPTO has given the DERMABAC trademark a serial number of 78169342. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, October 29, 2003. The DERMABAC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of dermatological disorders due to nanobacterial infection
dermabac

General Information


Serial Number78169342
Word MarkDERMABAC
Filing DateMonday, September 30, 2002
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, October 29, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of dermatological disorders due to nanobacterial infection
Pseudo MarkDERMATOLOGICAL BACTERIAL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 9, 2002
Primary Code005
First Use Anywhere DateMonday, September 30, 2002
First Use In Commerce DateMonday, September 30, 2002

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressTampa, FL 33607

Trademark Events


Event DateEvent Description
Wednesday, October 29, 2003ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 17, 2003NON-FINAL ACTION E-MAILED
Monday, March 17, 2003ASSIGNED TO EXAMINER